Health & Medicine
Bioprinting a 3D liver-like device to detoxify the blood
10 May 2014
The device, which is designed to be used outside the body , much like dialysis, uses nanoparticles to trap pore-forming toxins that can damage cellular membranes and are a key factor in illnesses that result from animal bites and stings, and bacterial infections
Eczema may reduce risk of skin cancer
07 May 2014
The immune response triggered by eczema could help prevent tumour formation by shedding potentially cancerous cells from the skin
First case of MERS detected in US
03 May 2014
10-year study shows 'Lethal Factor' could be X-factor for new anthrax vaccine
03 May 2014
Researchers have identified a section of the anthrax toxin Lethal Factor that could help produce a more effective vaccine
Estimating baby’s size gets more precise
30 Apr 2014
Today's statin users consume more calories and fat, and weigh more, than their predecessors
29 Apr 2014
People who take statin drugs to lower their cholesterol appear to have developed a false sense of security that could lead to heart disease and other obesity-related illnesses.
HIV gets deadlier: virus rooted in America, not Africa
29 Apr 2014
Apart from shedding fresh light on the origins of the deadly virus, which has its roots in the US, rather than Africa, new research has found HIV adapting itself to human immune systems
Study suggests more patients with emphysema could benefit from surgery
By By Francesca Davenport | 26 Apr 2014
Skin layer grown in lab could replace animal testing
26 Apr 2014
The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics
Greater investment needed to check malaria: WHO
25 Apr 2014
New pain relief targets discovered
24 Apr 2014
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
